CD274 and neoplasm: Moreover, we also detected the frequency of other PD-L1 positive immune cells, and BiPT-23 did not alter myeloid subset composition (Fig. 5C), which means BiPT-23 selectively depleted PD-L1+ tumor cells, other than PD-L1+ immune cells, consistent with another report28.